Preclinical and clinical development of immunocytokines.
about
Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.The development of antibody-IL-2 based immunotherapy with hu14.18-IL2 (EMD-273063) in melanoma and neuroblastoma.Anti-GD2 Strategy in the Treatment of NeuroblastomaIssues related to targeted delivery of proteins and peptides.Post-production protein stability: trouble beyond the cell factory.
P2860
Preclinical and clinical development of immunocytokines.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Preclinical and clinical development of immunocytokines.
@ast
Preclinical and clinical development of immunocytokines.
@en
type
label
Preclinical and clinical development of immunocytokines.
@ast
Preclinical and clinical development of immunocytokines.
@en
prefLabel
Preclinical and clinical development of immunocytokines.
@ast
Preclinical and clinical development of immunocytokines.
@en
P2093
P1476
Preclinical and clinical development of immunocytokines
@en
P2093
Jacquelyn A Hank
Mark R Albertini
Paul M Sondel
P304
P577
2003-06-01T00:00:00Z